Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1023/A:1010334831330 | DOI Listing |
J Adv Nurs
January 2025
Faculty of Health, School of Nursing, Queensland University of Technology, Kelvin Grove, Queensland, Australia.
Aim: To evaluate the impact of a participatory, action-oriented implementation study, guided by the integrated Promoting Action on Research Implementation in Health Services framework, for optimising pain care processes in a tertiary paediatric emergency department.
Design: Hybrid type 3 implementation effectiveness.
Methods: A collaborative appraisal of the context and culture of pain care informed two interdependent action cycles: Enabling nurse-initiated analgesia and involving families in pain care.
PLoS One
January 2025
Department of Construction and Quality Management, School of Science and Technology, Hong Kong Metropolitan University, Homantin Kowloon, Hong Kong SAR, China.
Industry 4.0 has transformed manufacturing with the integration of cutting-edge technology, posing crucial issues in the efficient task assignment to multi-tasking robots within smart factories. The paper outlines a unique method of decentralizing auctions to handle basic tasks.
View Article and Find Full Text PDFJ Infect Public Health
January 2025
Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, Ontario M5T 3M7, Canada; Department of Civil & Mineral Engineering, 35 St. George St, Toronto, Ontario M5S 1A4, Canada.
Throughout the COVID-19 pandemic, Canadian public health advisors and politicians have shared mixed messages about the utility of portable air filters (PAFs) for mitigating the transmission of airborne infectious diseases. Some public health advisors and decision-makers have also suggested that PAFs are cumbersome or require expert advice. We take this opportunity to review evidence and address myths about PAFs.
View Article and Find Full Text PDFRandomized controlled trials (RCTs) evaluating anti-cancer agents often lack generalizability to real-world oncology patients. Although restrictive eligibility criteria contribute to this issue, the role of selection bias related to prognostic risk remains unclear. In this study, we developed TrialTranslator, a framework designed to systematically evaluate the generalizability of RCTs for oncology therapies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!